1. Home
  2. CTBI vs PHAT Comparison

CTBI vs PHAT Comparison

Compare CTBI & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTBI
  • PHAT
  • Stock Information
  • Founded
  • CTBI 1903
  • PHAT 2018
  • Country
  • CTBI United States
  • PHAT United States
  • Employees
  • CTBI N/A
  • PHAT N/A
  • Industry
  • CTBI Major Banks
  • PHAT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTBI Finance
  • PHAT Health Care
  • Exchange
  • CTBI Nasdaq
  • PHAT Nasdaq
  • Market Cap
  • CTBI 1.0B
  • PHAT 820.8M
  • IPO Year
  • CTBI N/A
  • PHAT 2019
  • Fundamental
  • Price
  • CTBI $56.09
  • PHAT $11.00
  • Analyst Decision
  • CTBI Buy
  • PHAT Strong Buy
  • Analyst Count
  • CTBI 3
  • PHAT 5
  • Target Price
  • CTBI $59.00
  • PHAT $16.40
  • AVG Volume (30 Days)
  • CTBI 46.0K
  • PHAT 1.0M
  • Earning Date
  • CTBI 10-15-2025
  • PHAT 11-06-2025
  • Dividend Yield
  • CTBI 3.81%
  • PHAT N/A
  • EPS Growth
  • CTBI 17.47
  • PHAT N/A
  • EPS
  • CTBI 5.08
  • PHAT N/A
  • Revenue
  • CTBI $253,839,000.00
  • PHAT $114,039,000.00
  • Revenue This Year
  • CTBI $20.43
  • PHAT $207.52
  • Revenue Next Year
  • CTBI $4.40
  • PHAT $96.46
  • P/E Ratio
  • CTBI $10.95
  • PHAT N/A
  • Revenue Growth
  • CTBI 12.25
  • PHAT 1049.82
  • 52 Week Low
  • CTBI $44.60
  • PHAT $2.21
  • 52 Week High
  • CTBI $61.67
  • PHAT $19.71
  • Technical
  • Relative Strength Index (RSI)
  • CTBI 44.30
  • PHAT 46.33
  • Support Level
  • CTBI $55.35
  • PHAT $10.84
  • Resistance Level
  • CTBI $59.67
  • PHAT $13.00
  • Average True Range (ATR)
  • CTBI 0.98
  • PHAT 0.67
  • MACD
  • CTBI -0.38
  • PHAT -0.25
  • Stochastic Oscillator
  • CTBI 17.13
  • PHAT 7.41

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: